To date, cathepsin Z has been found to be involved in cancer models (22, 39, 40), rheumatoid arthritis (41), Alzheimer’s disease (42), Sjogren’s syndrome (43), and primary biliary cholangitis (44). This evidence concerns the gene CTSZ and Alzheimer disease.